Fluid management and risk factors for renal dysfunction in patients with severe sepsis and/or septic shock

Critical Care

Volumn 16, Issue 1, 2012, Pages

  Muller, Laurent ^a,b   Jaber, Samir ^c   Molinari, Nicolas ^a,b   Favier, Laurent ^d   Larché, Jérôme ^e   Motte, Gilles ^f   Lazarovici, Sonia ^g   Jacques, Luc ^h   Alonso, Sandrine ^a,b   Leone, Marc ⁱ   Constantin, Jean M ^j   Allaouchiche, Bernard ^k   Suehs, Carey ^a,b   Lefrant, Jean Yves ^a,b  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

^c HÔPITAL SAINT ELOI   (France)

^d Service de Réanimation   (France)

^e Centre Hospitalier de Narbonne   (France)

^f Centre Hospitalier de Perpignan   (France)

^g Service de Neurologie   (France)

^h Centre Hospitalier Intercommunal du Bassin de Thau   (France)

ⁱ AIX MARSEILLE UNIVERSITY   (France)

^j UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^k EDOUARD HERRIOT HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HETASTARCH; HYPERTENSIVE FACTOR; HES 130 0.4; HES 130-0.4;

ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; CRYSTALLOID; DISEASE SEVERITY; FEMALE; FLUID THERAPY; FRANCE; HUMAN; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; SAPS II SCORE; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SEX DIFFERENCE; SOFA SCORE; SURGICAL PATIENT; TREATMENT OUTCOME; ACUTE KIDNEY FAILURE; CHEMICALLY INDUCED DISORDER; DISEASE MANAGEMENT; DRUG EFFECT; KIDNEY; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY;

ACUTE KIDNEY INJURY; AGED; DISEASE MANAGEMENT; FEMALE; FLUID THERAPY; HETASTARCH; HUMANS; KIDNEY; MALE; MIDDLE AGED; RISK FACTORS; SEPSIS; SEX FACTORS; SHOCK, SEPTIC;

EID: 84857461107     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11213     Document Type: Article

References (41)

1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) investigators Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) investigators.
2. de Mendonca A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, Takala J, Sprung C, Cantraine F. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000, 26:915-921. 10.1007/s001340051281, 10990106.
3. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004, 30:536-555. 10.1007/s00134-004-2210-z, 14997291.
4. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005, 365:63-78. 10.1016/S0140-6736(04)17667-8, 15639681.
5. Brochard L, Abroug F, Brenner M, Broccard AF, Danner RL, Ferrer M, Laghi F, Magder S, Papazian L, Pelosi P, Polderman KH, ATS/ERS/ESICM/SCCM/SRLF AD HOC Committee on Acute Renal Failure An Official ATS/ERS/ESICM/SCCM/SRLF Statement: Prevention and Management of Acute Renal Failure in the ICU Patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med 2010, 181:1128-1155. 10.1164/rccm.200711-1664ST, 20460549, ATS/ERS/ESICM/SCCM/SRLF AD HOC Committee on Acute Renal Failure.
6. Dennen P, Douglas IS, Anderson R. Acute kidney injury in the intensive care unit: an update and primer for the intensivist. Crit Care Med 2010, 38:261-275. 10.1097/CCM.0b013e3181bfb0b5, 19829099.
7. Bayer O, Reinhart K, Sakr Y, Kabisch B, Kohl M, Riedemann NC, Bauer M, Settmacher U, Hekmat K, Hartog CS. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: A prospective sequential comparison. Crit Care Med 2011, 39:1335-1342. 10.1097/CCM.0b013e318212096a, 21358396.
8. Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 2011, 112:635-645. 10.1213/ANE.0b013e31820ad607, 21304149.
9. Hartog CS, Bauer M, Reinhart K. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg 2011, 112:156-164. 10.1213/ANE.0b013e3181eaff91, 21127276.
10. Hartog C, Reinhart K. CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients. Intensive Care Med 2009, 35:1337-1342. 10.1007/s00134-009-1521-5, 19533093.
11. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2007, CD000567.
12. McIlroy DR, Kharasch ED. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg 2003, 96:1572-1577.
13. Trof RJ, Sukul SP, Twisk JW, Girbes AR, Groeneveld AB. Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia. Intensive Care Med 2010, 36:697-701. 10.1007/s00134-010-1776-x, 2837190, 20165941.
14. Verheij J, van Lingen A, Beishuizen A, Christiaans HM, de Jong JR, Girbes AR, Wisselink W, Rauwerda JA, Huybregts MA, Groeneveld AB. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med 2006, 32:1030-1038. 10.1007/s00134-006-0195-5, 16791665.
15. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Matanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139. 10.1056/NEJMoa070716, 18184958, German Competence Network Sepsis (SepNet).
16. Ertmer C, Rehberg S, Van Aken H, Westphal M. Relevance of non-albumin colloids in intensive care medicine. Best Pract Res Clin Anaesthesiol 2009, 23:193-212. 10.1016/j.bpa.2008.11.001, 19653439.
17. Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: different products--different effects. Anesthesiology 2009, 111:187-202. 10.1097/ALN.0b013e3181a7ec82, 19512862.
18. Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J, Marx G, Vincent JL. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007, 98:216-224. 10.1093/bja/ael333, 17251213.
19. Boussekey N, Darmon R, Langlois J, Alfandari S, Devos P, Meybeck A, Chiche A, Georges H, Leroy O. Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Crit Care 2010, 14:R40. 10.1186/cc8920, 2887149, 20298543.
20. Wu Y, Wu AS, Wang J, Tian M, Jia XY, Rui Y, Yue Y. Effects of the novel 6% hydroxyethyl starch 130/0.4 on renal function of recipients in living-related kidney transplantation. Chin Med J (Engl) 2010, 123:3079-3083.
21. Blasco V, Leone M, Antonini F, Geissler A, Albanese J, Martin C. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth 2008, 100:504-508. 10.1093/bja/aen001, 18256055.
22. Bayer O, Reinhart K, Sakr Y, Kabisch B, Kohl M, Riedemann NC, Bauer M, Settmacher U, Hekmat K, Hartog CS. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: A prospective sequential comparison. Crit Care Med 2011, 39:1335-1342. 10.1097/CCM.0b013e318212096a, 21358396.
23. Lefrant JY, Muller L, Raillard A, Jung B, Beaudroit L, Favier L, Masson B, Dingemans G, Thevenot F, Selcer D, Jonquet O, Capdevila X, Fabbro-Peray P, Jaber S, Sepsi d'Oc Study Group in the AzuRéa Group Reduction of the severe sepsis or septic shock associated mortality by reinforcement of the recommendations bundle: a multicenter study. Ann Fr Anesth Reanim 2010, 29:621-628. 10.1016/j.annfar.2010.04.007, 20634026, Sepsi d'Oc Study Group in the AzuRéa Group.
24. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.1993.03510240069035, 8254858.
25. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
26. Fagon JY, Chastre J, Novara A, Medioni P, Gibert C. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med 1993, 19:137-144. 10.1007/BF01720528, 8315120.
27. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31. 10.1186/cc5713, 2206446, 17331245.
28. Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Diaz G, Garnacho-Montero J, Ibanez J, Palencia E, Quintana M, de la Torre-Prados MV. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008, 299:2294-2303. 10.1001/jama.299.19.2294, 18492971.
29. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010, 303:739-746. 10.1001/jama.2010.158, 2918907, 20179283.
30. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker M, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010, 36:222-231. 10.1007/s00134-009-1738-3, 2826633, 20069275.
31. Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, Willemsen SP, Bakker J. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 2010, 182:752-761. 10.1164/rccm.200912-1918OC, 20463176.
32. Castellanos-Ortega A, Suberviola B, Garcia-Astudillo LA, Holanda MS, Ortiz F, Llorca J, Delgado-Rodriguez M. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med 2010, 38:1036-1043. 10.1097/CCM.0b013e3181d455b6, 20154597.
33. Hartog CS, Brunkhorst FM, Bloos F, Bogatsch H, Engel C, Sengebusch K, Reinhart K, Ragaller M. Practice of volume therapy in patients with severe sepsis: results from a nationwide sepsis prevalence study. Intensive Care Med 2010, 36:553-554. 10.1007/s00134-009-1736-5, 19953220.
34. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377. 10.1056/NEJMoa010307, 11794169.
35. Bagshaw SM, Laupland KB, Doig CJ, Mortis G, Fick GH, Mucenski M, Godinez-Luna T, Svenson LW, Rosenal T. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care 2005, 9:R700-709. 10.1186/cc3879, 1414056, 16280066.
36. Badin J, Boulain T, Ehrmann S, Skarzynski M, Bretagnol A, Buret J, Benzekri-Lefevre D, Mercier E, Runge I, Garot D, Mathonnet A, Dequin PF, Perrotin D. Relation between mean arterial pressure and renal function in the early phase of shock: a prospective, explorative cohort study. Crit Care 2011, 15:R135. 10.1186/cc10253, 3219004, 21645384.
37. Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993, 342:248-249.
38. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996, 348:1620-1622. 10.1016/S0140-6736(96)07588-5, 8961992.
39. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001, 357:911-916. 10.1016/S0140-6736(00)04211-2, 11289347.
40. Schortgen F, Girou E, Deye N, Brochard L. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008, 34:2157-2168. 10.1007/s00134-008-1225-2, 18685828.
41. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353. 10.1097/01.CCM.0000194725.48928.3A, 16424713.